Z. Mitrovic

发表

[The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience].

R. Kusec, O. Jakšić, V. Pejsa, 2014, Lijecnicki vjesnik.

The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project

D. Weisenburger, J. Armitage, J. Vose, 2012, American journal of hematology.

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B‐cell lymphoma

W. C. Chan, J. Armitage, P. Bierman, 2012, British journal of haematology.

Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients

O. Jakšić, M. Lucijanić, V. Pejsa, 2017, Croatian medical journal.

Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia

O. Jakšić, M. Lucijanić, V. Pejsa, 2019, Leukemia & lymphoma.

Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis

R. Kusec, A. Livun, M. Lucijanić, 2017, International Journal of Hematology.

Treatment of Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma with Two Ifosfamide-Based Regimens, IMVP and ICE

R. štern-Padovan, B. Labar, I. Aurer, 2008, Journal of chemotherapy.

Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome

R. Kusec, A. Livun, O. Jakšić, 2016, Hematology.

CD43 expression is associated with inferior survival in the non‐germinal centre B‐cell subgroup of diffuse large B‐cell lymphoma

W. C. Chan, T. Greiner, J. Armitage, 2013, British journal of haematology.

Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases

I. Aurer, H. Holik, O. Jakšić, 2021, Blood.

Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases

I. Aurer, B. Coha, D. Radic-Kristo, 2021, Croatian medical journal.

Biological prognostic markers in diffuse large B-cell lymphoma.

W. Chan, Anamarija M. Perry, Z. Mitrović, 2012, Cancer control : journal of the Moffitt Cancer Center.

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

B. Labar, I. Aurer, S. Dotlić, 2010, Pathology & Oncology Research.

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

B. Labar, I. Aurer, M. Nola, 2009, International journal of hematology.

CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphoma.

B. Labar, I. Aurer, M. Nola, 2009, Clinical lymphoma & myeloma.

FCγRIIIA and FCγRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma

B. Labar, I. Aurer, I. Radman, 2007 .

Hereditary haemorrhagic telangiectasia – systematic review and single center experience

B. Radić, I. Grgurević, V. Pejsa, 2019, Liječnički vjesnik.

Psycho-organic symptoms as early manifestation of adult onset POMT1-related limb girdle muscular dystrophy

K. Bushby, H. Lochmüller, A. Huebner, 2014, Neuromuscular Disorders.

[Treatment of hairy cell leukemia with cladribine].

B. Labar, I. Aurer, J. Jakić-Razumović, 2007, Lijecnicki vjesnik.

The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis

O. Jakšić, M. Lucijanić, V. Pejsa, 2016, Acta Haematologica.

LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy.

B. Labar, A. Vince, R. Serventi-Seiwerth, 2008, Journal of medical microbiology.

Dose‐adjusted EPOCH and rituximab (DA‐EPOCH‐R) in older patients with high‐risk aggressive diffuse large B‐cell lymphoma: A real‐life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)

I. Aurer, H. Holik, P. Gaćina, 2023, European journal of haematology.

Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience

I. Aurer, Inga Mandac Smoljanović, F. Šantek, 2023, La radiologia medica.

Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients

P. Gaćina, O. Jakšić, M. Lucijanić, 2021, Wiener klinische Wochenschrift.

FCgammaRIIIA and FCgammaRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma.

B. Labar, I. Aurer, I. Radman, 2007, Haematologica.

Assessment of war and accidental nerve injuries in children.

N. Barišić, D. Jurenić, D. Perovic, 1999, Pediatric neurology.

Peroralna kombinacija lomustina, klorambucila, etopozida i prednizona (CCEP) u liječenju bolesnika s uznapredovanim limfomom

B. Labar, I. Radman, S. Kinda, 2011 .

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma

S. Mazič, M. Kralik, B. Labar, 2016, Annals of Hematology.

CD13+ anaplastic large cell lymphoma with leukemic presentation and additional chromosomal abnormality

M. Nola, M. Sučić, S. Ries, 2009, Diagnostic cytopathology.

LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy.

B. Labar, A. Vince, I. Grgic, 2008, Journal of medical microbiology.

H. Holik, S. Bašić-Kinda, Slobodanka Ostojić-Kolonić, 2024, Biomedicines.

Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience

Inga Mandac Smoljanović, F. Šantek, S. Bašić-Kinda, 2024, Cancers.